As he said at the OrgZdrav 2021 congress, this form of the vaccine has already been produced since March of this year, and it has shown stability.
"Vector" has submitted documents for registration of the new form in the Ministry of Health.
"I expect that by mid-June a change will be made to the registration certificate and we will have an additional new form of the possibility of using the vaccine - not only in the form of ampoules, but also in the format of syringe doses," RIA Novosti quotes Maksyutov.
Earlier it was reported that the first results of clinical trials of the EpiVacCorona-N coronavirus vaccine will not appear until autumn.
At the same time, Alexander Gintsburg, director of the Gamaleya Research Center for Epidemiology and Microbiology of the Russian Ministry of Health, said that registration of a nasal vaccine against coronavirus infection could occur in 2022.